{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:47:36Z","timestamp":1792802856924,"version":"4.5.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cancer"],"published-print":{"date-parts":[[2009,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide with an extremely poor prognosis. The classification of HCC based on the molecular signature is not well-established.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>In the present study, we reported HCC signature genes based on the JNK1 activation status in 31 HCC specimens relative to the matched distal noncancerous liver tissue from 31 patients. The HCCs with high JNK1 (H-JNK1) and low JNK1 (L-JNK1) were sub-grouped. Two different signature gene sets for both H-JNK1 and L-JNK1 HCC were identified through gene expression profiling. A striking overlap of signature genes was observed between the H-JNK1 HCC and the hepatoblastoma or hepatoblastoma-type HCC. Many established biomarkers for hepatic progenitor cells were over-expressed in H-JNK1 HCC, including AFP, TACSTD1, KRT19, KRT7, THY1, and PROM1. In addition, the majority of the most up-regulated genes were those associated with metastasis and earlier recurrence, whereas the genes for normal liver function were substantially down-regulated in H-JNK1 HCC tissue. A Kaplan-Meier plot demonstrated that the survival of the patients with H-JNK1 HCC was severely impaired.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Accordingly, we believe that the H-JNK1 HCC may originate from hepatic progenitor cells and is associated with poorer prognosis. The status of JNK1 activation in HCC tissue, thus, might be a new biomarker for HCC prognosis and therapeutic targeting.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1476-4598-8-64","type":"journal-article","created":{"date-parts":[[2009,8,18]],"date-time":"2009-08-18T06:13:42Z","timestamp":1250576022000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":64,"title":["JNK1 activation predicts the prognostic outcome of the human hepatocellular carcinoma"],"prefix":"10.1186","volume":"8","author":[{"given":"Qingshan","family":"Chang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianguo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin J","family":"Beezhold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vince","family":"Castranova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianglin","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,8,17]]},"reference":[{"key":"449_CR1","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1002\/hep.22506","volume":"48","author":"JM Llovet","year":"2008","unstructured":"Llovet JM, Bruix J: Molecular targeted therapies in hepatocellular carcinoma. Hepatology. 2008, 48: 1312-1327. 10.1002\/hep.22506","journal-title":"Hepatology"},{"key":"449_CR2","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1038\/ng0802-339","volume":"31","author":"SS Thorgeirsson","year":"2002","unstructured":"Thorgeirsson SS, Grisham JW: Molecular pathogenesis of human hepatocellular carcinoma. Nat Genet. 2002, 31: 339-346. 10.1038\/ng0802-339","journal-title":"Nat Genet"},{"key":"449_CR3","doi-asserted-by":"publisher","first-page":"2224","DOI":"10.1111\/j.1572-0241.1999.01297.x","volume":"94","author":"N Chalasani","year":"1999","unstructured":"Chalasani N, Said A, Ness R, Hoen H, Lumeng L: Screening for hepatocellular carcinoma in patients with cirrhosis in the United States: results of a national survey. Am J Gastroenterol. 1999, 94: 2224-2229. 10.1111\/j.1572-0241.1999.01297.x","journal-title":"Am J Gastroenterol"},{"key":"449_CR4","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1038\/nrc1934","volume":"6","author":"PA Farazi","year":"2006","unstructured":"Farazi PA, DePinho RA: Hepatocellular carcinoma pathogenesis: from genes to environment. Nat Rev Cancer. 2006, 6: 674-687. 10.1038\/nrc1934","journal-title":"Nat Rev Cancer"},{"key":"449_CR5","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/S1542-3565(04)00353-2","volume":"2","author":"MH Nguyen","year":"2004","unstructured":"Nguyen MH, Whittemore AS, Garcia RT, Tawfeek SA, Ning J, Lam S, Wright TL, Keeffe EB: Role of ethnicity in risk for hepatocellular carcinoma in patients with chronic hepatitis C and cirrhosis. Clin Gastroenterol Hepatol. 2004, 2: 820-824. 10.1016\/S1542-3565(04)00353-2","journal-title":"Clin Gastroenterol Hepatol"},{"key":"449_CR6","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1007\/s00535-007-2064-6","volume":"42","author":"VK Rustgi","year":"2007","unstructured":"Rustgi VK: The epidemiology of hepatitis C infection in the United States. J Gastroenterol. 2007, 42: 513-521. 10.1007\/s00535-007-2064-6","journal-title":"J Gastroenterol"},{"key":"449_CR7","doi-asserted-by":"publisher","first-page":"3866","DOI":"10.1038\/sj.onc.1209550","volume":"25","author":"MA Avila","year":"2006","unstructured":"Avila MA, Berasain C, Sangro B, Prieto J: New therapies for hepatocellular carcinoma. Oncogene. 2006, 25: 3866-3884. 10.1038\/sj.onc.1209550","journal-title":"Oncogene"},{"key":"449_CR8","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.jhep.2007.11.007","volume":"48","author":"J Prieto","year":"2008","unstructured":"Prieto J: Inflammation, HCC and sex: IL-6 in the centre of the triangle. J Hepatol. 2008, 48: 380-381. 10.1016\/j.jhep.2007.11.007","journal-title":"J Hepatol"},{"key":"449_CR9","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1002\/hep.20375","volume":"40","author":"JS Lee","year":"2004","unstructured":"Lee JS, Chu IS, Heo J, Calvisi DF, Sun Z, Roskams T, Durnez A, Demetris AJ, Thorgeirsson SS: Classification and prediction of survival in hepatocellular carcinoma by gene expression profiling. Hepatology. 2004, 40: 667-676. 10.1002\/hep.20375","journal-title":"Hepatology"},{"key":"449_CR10","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1007\/s00595-006-3276-8","volume":"36","author":"WS Lee","year":"2006","unstructured":"Lee WS, Lee KW, Heo JS, Kim SJ, Choi SH, Kim YI, Joh JW: Comparison of combined hepatocellular and cholangiocarcinoma with hepatocellular carcinoma and intrahepatic cholangiocarcinoma. Surg Today. 2006, 36: 892-897. 10.1007\/s00595-006-3276-8","journal-title":"Surg Today"},{"key":"449_CR11","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1053\/j.gastro.2008.08.008","volume":"135","author":"A Villanueva","year":"2008","unstructured":"Villanueva A, Chiang DY, Newell P, Peix J, Thung S, Alsinet C, Tovar V, Roayaie S, Minguez B, Sole M, Battiston C, Van Laarhoven S, Fiel MI, Di Feo A, Hoshida Y, Yea S, Toffanin S, Ramos A, Martignetti JA, Mazzaferro V, Bruix J, Waxman S, Schwartz M, Meyerson M, Friedman SL, Llovet JM: Pivotal role of mTOR signaling in hepatocellular carcinoma. Gastroenterology. 2008, 135: 1972-1983. 1983 e1971-1911., 10.1053\/j.gastro.2008.08.008","journal-title":"Gastroenterology"},{"key":"449_CR12","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1053\/j.gastro.2008.12.004","volume":"136","author":"T Yamashita","year":"2009","unstructured":"Yamashita T, Ji J, Budhu A, Forgues M, Yang W, Wang HY, Jia H, Ye Q, Qin LX, Wauthier E, Reid LM, Minato H, Honda M, Kaneko S, Tang ZY, Wang XW: EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem\/progenitor cell features. Gastroenterology. 2009, 136: 1012-1024. 10.1053\/j.gastro.2008.12.004","journal-title":"Gastroenterology"},{"key":"449_CR13","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.jhep.2008.07.037","volume":"50","author":"Q Chang","year":"2009","unstructured":"Chang Q, Zhang Y, Beezhold KJ, Bhatia D, Zhao H, Chen J, Castranova V, Shi X, Chen F: Sustained JNK1 activation is associated with altered histone H3 methylations in human liver cancer. J Hepatol. 2009, 50: 323-333. 10.1016\/j.jhep.2008.07.037","journal-title":"J Hepatol"},{"key":"449_CR14","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.4161\/cc.8.8.8200","volume":"8","author":"F Chen","year":"2009","unstructured":"Chen F, Castranova V: Beyond apoptosis of JNK1 in liver cancer. Cell Cycle. 2009, 8: 1145-1147.","journal-title":"Cell Cycle"},{"key":"449_CR15","doi-asserted-by":"publisher","first-page":"3943","DOI":"10.1172\/JCI37156","volume":"118","author":"L Hui","year":"2008","unstructured":"Hui L, Zatloukal K, Scheuch H, Stepniak E, Wagner EF: Proliferation of human HCC cells and chemically induced mouse liver cancers requires JNK1-dependent p21 downregulation. J Clin Invest. 2008, 118: 3943-3953. 10.1172\/JCI37156","journal-title":"J Clin Invest"},{"key":"449_CR16","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.ccr.2008.11.002","volume":"14","author":"S Cairo","year":"2008","unstructured":"Cairo S, Armengol C, De Reynies A, Wei Y, Thomas E, Renard CA, Goga A, Balakrishnan A, Semeraro M, Gresh L, Pontoglio M, Strick-Marchand H, Levillayer F, Nouet Y, Rickman D, Gauthier F, Branchereau S, Brugieres L, Laithier V, Bouvier R, Boman F, Basso G, Michiels JF, Hofman P, Arbez-Gindre F, Jouan H, Rousselet-Chapeau MC, Berrebi D, Marcellin L, Plenat F, Zachar D, Joubert M, Selves J, Pasquier D, Bioulac-Sage P, Grotzer M, Childs M, Fabre M, Buendia MA: Hepatic stem-like phenotype and interplay of Wnt\/beta-catenin and Myc signaling in aggressive childhood liver cancer. Cancer Cell. 2008, 14: 471-484. 10.1016\/j.ccr.2008.11.002","journal-title":"Cancer Cell"},{"key":"449_CR17","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1055\/s-2007-991514","volume":"27","author":"MJ Czaja","year":"2007","unstructured":"Czaja MJ: Cell signaling in oxidative stress-induced liver injury. Semin Liver Dis. 2007, 27: 378-389. 10.1055\/s-2007-991514","journal-title":"Semin Liver Dis"},{"key":"449_CR18","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1002\/hep.22578","volume":"49","author":"R Singh","year":"2009","unstructured":"Singh R, Wang Y, Xiang Y, Tanaka KE, Gaarde WA, Czaja MJ: Differential effects of JNK1 and JNK2 inhibition on murine steatohepatitis and insulin resistance. Hepatology. 2009, 49: 87-96. 10.1002\/hep.22578","journal-title":"Hepatology"},{"key":"449_CR19","doi-asserted-by":"publisher","first-page":"10544","DOI":"10.1073\/pnas.0603499103","volume":"103","author":"T Sakurai","year":"2006","unstructured":"Sakurai T, Maeda S, Chang L, Karin M: Loss of hepatic NF-kappa B activity enhances chemical hepatocarcinogenesis through sustained c-Jun N-terminal kinase 1 activation. Proc Natl Acad Sci USA. 2006, 103: 10544-10551. 10.1073\/pnas.0603499103","journal-title":"Proc Natl Acad Sci USA"},{"key":"449_CR20","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1053\/j.gastro.2006.09.014","volume":"131","author":"JM Llovet","year":"2006","unstructured":"Llovet JM, Chen Y, Wurmbach E, Roayaie S, Fiel MI, Schwartz M, Thung SN, Khitrov G, Zhang W, Villanueva A, Battiston C, Mazzaferro V, Bruix J, Waxman S, Friedman SL: A molecular signature to discriminate dysplastic nodules from early hepatocellular carcinoma in HCV cirrhosis. Gastroenterology. 2006, 131: 1758-1767. 10.1053\/j.gastro.2006.09.014","journal-title":"Gastroenterology"},{"key":"449_CR21","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1091\/mbc.02-02-0023.","volume":"13","author":"X Chen","year":"2002","unstructured":"Chen X, Cheung ST, So S, Fan ST, Barry C, Higgins J, Lai KM, Ji J, Dudoit S, Ng IO, Rijn Van De M, Botstein D, Brown PO: Gene expression patterns in human liver cancers. Mol Biol Cell. 2002, 13: 1929-1939. 10.1091\/mbc.02-02-0023.","journal-title":"Mol Biol Cell"},{"key":"449_CR22","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1038\/nm1377","volume":"12","author":"JS Lee","year":"2006","unstructured":"Lee JS, Heo J, Libbrecht L, Chu IS, Kaposi-Novak P, Calvisi DF, Mikaelyan A, Roberts LR, Demetris AJ, Sun Z, Nevens F, Roskams T, Thorgeirsson SS: A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells. Nat Med. 2006, 12: 410-416. 10.1038\/nm1377","journal-title":"Nat Med"},{"key":"449_CR23","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1002\/hep.21467","volume":"45","author":"S Boyault","year":"2007","unstructured":"Boyault S, Rickman DS, de Reynies A, Balabaud C, Rebouissou S, Jeannot E, Herault A, Saric J, Belghiti J, Franco D, Bioulac-Sage P, Laurent-Puig P, Zucman-Rossi J: Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets. Hepatology. 2007, 45: 42-52. 10.1002\/hep.21467","journal-title":"Hepatology"},{"key":"449_CR24","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1038\/nm843","volume":"9","author":"QH Ye","year":"2003","unstructured":"Ye QH, Qin LX, Forgues M, He P, Kim JW, Peng AC, Simon R, Li Y, Robles AI, Chen Y, Ma ZC, Wu ZQ, Ye SL, Liu YK, Tang ZY, Wang XW: Predicting hepatitis B virus-positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning. Nat Med. 2003, 9: 416-423. 10.1038\/nm843","journal-title":"Nat Med"},{"key":"449_CR25","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1111\/j.1365-3083.2006.001766.x","volume":"63","author":"C Rubie","year":"2006","unstructured":"Rubie C, Frick VO, Wagner M, Rau B, Weber C, Kruse B, Kempf K, Tilton B, Konig J, Schilling M: Enhanced expression and clinical significance of CC-chemokine MIP-3 alpha in hepatocellular carcinoma. Scand J Immunol. 2006, 63: 468-477. 10.1111\/j.1365-3083.2006.001766.x","journal-title":"Scand J Immunol"},{"key":"449_CR26","doi-asserted-by":"publisher","first-page":"2056","DOI":"10.1158\/1078-0432.CCR-07-1473","volume":"14","author":"HG Woo","year":"2008","unstructured":"Woo HG, Park ES, Cheon JH, Kim JH, Lee JS, Park BJ, Kim W, Park SC, Chung YJ, Kim BG, Yoon JH, Lee HS, Kim CY, Yi NJ, Suh KS, Lee KU, Chu IS, Roskams T, Thorgeirsson SS, Kim YJ: Gene expression-based recurrence prediction of hepatitis B virus-related human hepatocellular carcinoma. Clin Cancer Res. 2008, 14: 2056-2064. 10.1158\/1078-0432.CCR-07-1473","journal-title":"Clin Cancer Res"},{"key":"449_CR27","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/1471-2105-6-97","volume":"6","author":"LR Grate","year":"2005","unstructured":"Grate LR: Many accurate small-discriminatory feature subsets exist in microarray transcript data: biomarker discovery. BMC Bioinformatics. 2005, 6: 97- 10.1186\/1471-2105-6-97","journal-title":"BMC Bioinformatics"},{"key":"449_CR28","doi-asserted-by":"publisher","first-page":"e845","DOI":"10.1371\/journal.pone.0000845","volume":"2","author":"IJ Matouk","year":"2007","unstructured":"Matouk IJ, DeGroot N, Mezan S, Ayesh S, Abu-lail R, Hochberg A, Galun E: The H19 non-coding RNA is essential for human tumor growth. PLoS ONE. 2007, 2: e845- 10.1371\/journal.pone.0000845","journal-title":"PLoS ONE"},{"key":"449_CR29","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1136\/mp.51.1.21","volume":"51","author":"I Ariel","year":"1998","unstructured":"Ariel I, Miao HQ, Ji XR, Schneider T, Roll D, de Groot N, Hochberg A, Ayesh S: Imprinted H19 oncofetal RNA is a candidate tumour marker for hepatocellular carcinoma. Mol Pathol. 1998, 51: 21-25. 10.1136\/mp.51.1.21","journal-title":"Mol Pathol"},{"key":"449_CR30","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1016\/j.ejca.2006.11.020","volume":"43","author":"YC Lee","year":"2007","unstructured":"Lee YC, Pan HW, Peng SY, Lai PL, Kuo WS, Ou YH, Hsu HC: Overexpression of tumour-associated trypsin inhibitor (TATI) enhances tumour growth and is associated with portal vein invasion, early recurrence and a stage-independent prognostic factor of hepatocellular carcinoma. Eur J Cancer. 2007, 43: 736-744. 10.1016\/j.ejca.2006.11.020","journal-title":"Eur J Cancer"},{"key":"449_CR31","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1002\/ijc.22605","volume":"121","author":"K Ieta","year":"2007","unstructured":"Ieta K, Ojima E, Tanaka F, Nakamura Y, Haraguchi N, Mimori K, Inoue H, Kuwano H, Mori M: Identification of overexpressed genes in hepatocellular carcinoma, with special reference to ubiquitin-conjugating enzyme E2C gene expression. Int J Cancer. 2007, 121: 33-38. 10.1002\/ijc.22605","journal-title":"Int J Cancer"},{"key":"449_CR32","doi-asserted-by":"publisher","first-page":"5578","DOI":"10.1038\/onc.2008.168","volume":"27","author":"YL Liao","year":"2008","unstructured":"Liao YL, Sun YM, Chau GY, Chau YP, Lai TC, Wang JL, Horng JT, Hsiao M, Tsou AP: Identification of SOX4 target genes using phylogenetic footprinting-based prediction from expression microarrays suggests that overexpression of SOX4 potentiates metastasis in hepatocellular carcinoma. Oncogene. 2008, 27: 5578-5589. 10.1038\/onc.2008.168. 10.1038\/onc.2008.168","journal-title":"Oncogene"},{"key":"449_CR33","first-page":"1223","volume":"27","author":"E Yumoto","year":"2005","unstructured":"Yumoto E, Nakatsukasa H, Hanafusa T, Yumoto Y, Nouso K, Matsumoto E, Onishi T, Takuma Y, Tanaka H, Fujikawa T, Suzuki M, Uemura M, Shiratori Y: IGFBP-3 expression in hepatocellular carcinoma involves abnormalities in TGF-beta and\/or Rb signaling pathways. Int J Oncol. 2005, 27: 1223-1230.","journal-title":"Int J Oncol"},{"key":"449_CR34","doi-asserted-by":"publisher","first-page":"5953","DOI":"10.1002\/pmic.200500460","volume":"6","author":"JF Cui","year":"2006","unstructured":"Cui JF, Liu YK, Zhang LJ, Shen HL, Song HY, Dai Z, Yu YL, Zhang Y, Sun RX, Chen J, Tang ZY, Yang PY: Identification of metastasis candidate proteins among HCC cell lines by comparative proteome and biological function analysis of S100A4 in metastasis in vitro. Proteomics. 2006, 6: 5953-5961. 10.1002\/pmic.200500460","journal-title":"Proteomics"},{"key":"449_CR35","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1056\/NEJMoa0804525","volume":"359","author":"Y Hoshida","year":"2008","unstructured":"Hoshida Y, Villanueva A, Kobayashi M, Peix J, Chiang DY, Camargo A, Gupta S, Moore J, Wrobel MJ, Lerner J, Reich M, Chan JA, Glickman JN, Ikeda K, Hashimoto M, Watanabe G, Daidone MG, Roayaie S, Schwartz M, Thung S, Salvesen HB, Gabriel S, Mazzaferro V, Bruix J, Friedman SL, Kumada H, Llovet JM, Golub TR: Gene expression in fixed tissues and outcome in hepatocellular carcinoma. N Engl J Med. 2008, 359: 1995-2004. 10.1056\/NEJMoa0804525","journal-title":"N Engl J Med"},{"key":"449_CR36","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1002\/hep.20053","volume":"39","author":"JW Kim","year":"2004","unstructured":"Kim JW, Ye Q, Forgues M, Chen Y, Budhu A, Sime J, Hofseth LJ, Kaul R, Wang XW: Cancer-associated molecular signature in the tissue samples of patients with cirrhosis. Hepatology. 2004, 39: 518-527. 10.1002\/hep.20053","journal-title":"Hepatology"},{"key":"449_CR37","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1002\/hep.20105","volume":"39","author":"SY Neo","year":"2004","unstructured":"Neo SY, Leow CK, Vega VB, Long PM, Islam AF, Lai PB, Liu ET, Ren EC: Identification of discriminators of hepatoma by gene expression profiling using a minimal dataset approach. Hepatology. 2004, 39: 944-953. 10.1002\/hep.20105","journal-title":"Hepatology"},{"key":"449_CR38","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1002\/hep.20286","volume":"40","author":"C Ovejero","year":"2004","unstructured":"Ovejero C, Cavard C, Perianin A, Hakvoort T, Vermeulen J, Godard C, Fabre M, Chafey P, Suzuki K, Romagnolo B, Yamagoe S, Perret C: Identification of the leukocyte cell-derived chemotaxin 2 as a direct target gene of beta-catenin in the liver. Hepatology. 2004, 40: 167-176. 10.1002\/hep.20286","journal-title":"Hepatology"},{"key":"449_CR39","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1046\/j.1440-1827.1999.00836.x","volume":"49","author":"T Uchida","year":"1999","unstructured":"Uchida T, Nagai H, Gotoh K, Kanagawa H, Kouyama H, Kawanishi T, Mima S, Yamagoe S, Suzuki K: Expression pattern of a newly recognized protein, LECT2, in hepatocellular carcinoma and its premalignant lesion. Pathol Int. 1999, 49: 147-151. 10.1046\/j.1440-1827.1999.00836.x","journal-title":"Pathol Int"},{"key":"449_CR40","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1111\/j.1478-3231.2005.01033.x","volume":"25","author":"G Zollner","year":"2005","unstructured":"Zollner G, Wagner M, Fickert P, Silbert D, Fuchsbichler A, Zatloukal K, Denk H, Trauner M: Hepatobiliary transporter expression in human hepatocellular carcinoma. Liver Int. 2005, 25: 367-379. 10.1111\/j.1478-3231.2005.01033.x","journal-title":"Liver Int"},{"key":"449_CR41","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1158\/0008-5472.CAN-07-6013","volume":"68","author":"T Yamashita","year":"2008","unstructured":"Yamashita T, Forgues M, Wang W, Kim JW, Ye Q, Jia H, Budhu A, Zanetti KA, Chen Y, Qin LX, Tang ZY, Wang XW: EpCAM and alpha-fetoprotein expression defines novel prognostic subtypes of hepatocellular carcinoma. Cancer Res. 2008, 68: 1451-1461. 10.1158\/0008-5472.CAN-07-6013","journal-title":"Cancer Res"},{"key":"449_CR42","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1038\/sj.onc.1210811","volume":"27","author":"S Ma","year":"2008","unstructured":"Ma S, Lee TK, Zheng BJ, Chan KW, Guan XY: CD133+ HCC cancer stem cells confer chemoresistance by preferential expression of the Akt\/PKB survival pathway. Oncogene. 2008, 27: 1749-1758. 10.1038\/sj.onc.1210811","journal-title":"Oncogene"},{"key":"449_CR43","doi-asserted-by":"publisher","first-page":"3818","DOI":"10.1038\/sj.onc.1209558","volume":"25","author":"T Roskams","year":"2006","unstructured":"Roskams T: Liver stem cells and their implication in hepatocellular and cholangiocarcinoma. Oncogene. 2006, 25: 3818-3822. 10.1038\/sj.onc.1209558","journal-title":"Oncogene"},{"key":"449_CR44","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1126\/science.1140485","volume":"317","author":"WE Naugler","year":"2007","unstructured":"Naugler WE, Sakurai T, Kim S, Maeda S, Kim K, Elsharkawy AM, Karin M: Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production. Science. 2007, 317: 121-124. 10.1126\/science.1140485","journal-title":"Science"},{"key":"449_CR45","doi-asserted-by":"publisher","first-page":"5945","DOI":"10.3748\/wjg.14.5945","volume":"14","author":"M Kalra","year":"2008","unstructured":"Kalra M, Mayes J, Assefa S, Kaul AK, Kaul R: Role of sex steroid receptors in pathobiology of hepatocellular carcinoma. World J Gastroenterol. 2008, 14: 5945-5961. 10.3748\/wjg.14.5945","journal-title":"World J Gastroenterol"}],"container-title":["Molecular Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1476-4598-8-64.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,31]],"date-time":"2021-08-31T23:22:12Z","timestamp":1630452132000},"score":1,"resource":{"primary":{"URL":"https:\/\/molecular-cancer.biomedcentral.com\/articles\/10.1186\/1476-4598-8-64"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8,17]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["449"],"URL":"https:\/\/doi.org\/10.1186\/1476-4598-8-64","relation":{},"ISSN":["1476-4598"],"issn-type":[{"value":"1476-4598","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,8,17]]},"assertion":[{"value":"19 April 2009","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2009","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2009","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"64"}}